Coverage for Mammograms and Supplemental Breast Cancer Screenings
SB 1578 expands breast cancer screening coverage in Florida across Medicaid, individual health insurance policies, group/blanket/franchise policies, and health maintenance contracts. It requires coverage for annual mammograms for women age 50 and older, biennial mammograms for women ages 40 to 49, and at least one baseline mammogram annually for women ages 35 to 39. The bill also requires coverage for supplemental breast cancer screenings, such as MRI, ultrasound, or molecular breast imaging, when medically necessary and recommended by a treating provider under American College of Radiology guidelines.
For Medicaid, the bill creates a new section requiring the Agency for Health Care Administration to cover one mammogram and, when certain risk factors are present, one supplemental breast cancer screening each year for women age 25 and older, subject to available funds and any appropriations limits. The agency must seek federal approval if needed. The bill also updates insurance statutes to define supplemental breast cancer screening and to require coverage for women at elevated risk, including those with dense breast tissue, personal or family history of breast cancer, benign breast disease, genetic predisposition, ancestry, or other physician-determined risk factors.
The bill would amend Florida insurance and Medicaid law by adding a new Medicaid screening benefit and by broadening mandated coverage requirements for private insurers and health maintenance organizations. It affects sections 409.9064, 627.6418, 627.6613, and 641.31095, and applies to policies and contracts issued, amended, delivered, or renewed on or after July 1, 2025. The legislation would likely increase access to earlier detection services and could increase costs for Medicaid and regulated health plans, while allowing coverage to remain subject to deductibles and coinsurance unless purchased as an enhanced option.
The available voting history suggests strong and consistent support for the bill. It passed the Senate Banking and Insurance committee unanimously, then received unanimous approval in the Senate Appropriations Committee on Health and Human Services and the Senate Fiscal Policy committee. No committee transcripts were provided, but the unanimous votes indicate broad bipartisan agreement and little visible opposition at the committee stage.
The main policy issues embedded in the bill are cost, scope, and implementation. For Medicaid, coverage is expressly conditioned on available funds and legislative appropriations, and the agency must obtain federal approval if required, which could limit or delay implementation. In the private insurance provisions, the bill expands mandated benefits and broadens the circumstances under which supplemental screening must be covered, which may raise premium and utilization concerns for insurers. The bill also leaves some discretion to treating physicians and references American College of Radiology guidelines, which could prompt debate over medical necessity standards and how broadly risk-based screening should be applied.